Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...

Online health and wellness company Hims & Hers raised $1 billion through convertible senior notes to grow its international ...

Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.

CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.

Hims & Hers (NASDAQ:HIMS), a telehealth platform with a market capitalization of $14 billion, has seen its stock rise by 150% this year. The stock now trades at over 10x trailing revenues ...

We recently published a list of 10 Firms Crushing the Market. In this article, we are going to take a look at where Hims & ...

In this week’s edition of InnovationRx, we look at Trump's drug pricing executive order, how the cofounder of Hims became a ...

Hims & Hers Health shares fell 4.1% Wednesday morning. Despite the pullback, the stock remains up an impressive 116% over the past month. Don’t miss this list of 3 high-yield stocks—including ...

There's a well-known saying in the investing world, which advises investors to "sell in May and go away." Historically, that ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Quantitative Momentum Investor model based on the ...